The product is indicated for the treatment of symptoms of inflammation and pruritus in psoriasis (excluding disseminated psoriatic plaques) and atopic dermatitis in adults and children.
Active substance in 1 g cream: mometasone furoate of 1 mg.
Excipient(s) with known effect: stearyl alcohol
The product is indicated for the treatment of symptoms of inflammation and pruritus in psoriasis (excluding disseminated psoriatic plaques) and atopic dermatitis in adults and children.
• Adults and elderly (over 65 years)
A thin layer of the cream is applied once daily on the affected skin areas.
Upon application of the product on the skin of the face, the minimum effective therapeutic dose should be used and the duration of treatment should be no longer than 5 days.
• Children
The treatment with the product should be carried out at the minimum effective therapeutic dose and
the duration should be no longer than 5 days. Patients with impaired renal and/or hepatic function
No adjustment of the recommended dose is required.
